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Abstract
The incidence of non-thermophilic Campylobacter species was assessed in an unselected population-based study in a mixed urban and
rural community in North Jutland, Denmark. In a 2-year study period, 11 314 faecal samples from 8302 patients with gastroenteritis
were cultured with supplement of the ﬁlter method. We recovered a high incidence of Campylobacter concisus (annual incidence 35/
100 000 inhabitants), almost as high as the common Campylobacter jejuni/coli. In contrast, there was a very low incidence of other
non-thermophilic Campylobacter species, such as Campylobacter upsaliensis. Campylobacter concisus was, unlike C. jejuni/coli, found more fre-
quently among small children (<1 year) and the elderly (‡65 years). Around 10% of the patients with C. consisus had co-infections domi-
nated by Clostridium difﬁcile and Salmonella enterica, whereas co-infections occurred in about 5% of C. jejuni/coli patients. We observed a
seasonal variation in C. jejuni/coli with a peak incidence in late summer months and autumn, whereas there was an almost constant
monthly prevalence of C. concisus. Among patients participating in a questionnaire sub-study, there was a higher degree of close contacts
with animals, especially dogs, as well as a higher travel exposure among C. jejuni/coli patients compared with C. concisus patients. We did
not culture any C. concisus in stool samples from a small cohort of healthy individuals. Future studies have to focus on the clinical fol-
low-up and the long-term risk of inﬂammatory bowel diseases in C. concisus-positive patients. We conclude that there is a high incidence
of C. concisus in Denmark.
Keywords: Age distribution, Campylobacter concisus, Campylobacter jejuni, gastroenteritis, incidence, prevalence, seasonal variation
Original Submission: 19 December 2011; Revised Submission: 15 March 2012; Accepted: 15 March 2012
Editor: S. Cutler
Article published online: 27 March 2012
Clin Microbiol Infect 2013; 19: 445–450
10.1111/j.1469-0691.2012.03852.x
Corresponding author: H. L. Nielsen, Department of Infectious
Diseases, Aalborg Hospital, Aarhus University Hospital, Hobrovej
18–22, DK-9000 Aalborg, Denmark
E-mail: halin@rn.dk
Introduction
Campylobacter concisus, ﬁrst described in 1981 when it was
isolated from the human oral cavity, has been proposed as
an emerging pathogen of the human intestinal tract [1,2]. It
is a fastidious, hydrogen-requiring and slow-growing, gram-
negative, s-shaped or curved bacterium with an optimum
temperature of about 37C for growth. As opposed to the
thermophilic Campylobacter jejuni/coli, no animal reservoirs
have been found for C. concisus, although it has been
detected in diarrhoeic faecal samples from domestic dogs
and recently C. concisus was cultured from fresh meat and
poultry [3,4]. Previously, C. concisus was associated with gin-
givitis and peridontitis, but it has also been found in healthy
oral sites [5,6]. The human oral cavity might be a reservoir
of C. concisus, but data are sparse on how C. concisus colo-
nizes the intestinal tract.
In vitro C. concisus has been shown to possess virulence
factors that include secreted as well as cell-bound haemolytic
activities [7,8]. Campylobacter concisus has also shown ability
to invade intestinal epithelial cells, and faecal as well as oral
isolates of C. concisus induce apoptotic leaks together with a
reduced expression level of the tight junction protein clau-
din-5 in HT29/B6 epithelial cells [9,10]. These ﬁndings dem-
onstrate a leak-ﬂux mechanism that is similar to the clinical
manifestation of diarrhoea.
In recent years a lot of attention has been given to bacte-
rial agents and their potential role for triggering inﬂamma-
tory bowel diseases [11,12]. High prevalence of C. concisus
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has been found in faecal samples and colonic biopsies of chil-
dren with Crohn’s disease, as well as in biopsy samples from
adults with ulcerative colitis, suggesting that the bacteria may
be involved in the intestinal inﬂammation seen in patients
with inﬂammatory bowel disease [13,14].
The clinical epidemiology of C. concisus is unclear, and no
study has reported its incidence in the general population.
There are studies describing a high incidence of C. concisus in
paediatric diarrhoeic stool samples and in immunocompro-
mised patients with diarrhoea in a tertiary hospital setting;
however, it has also occasionally been found in healthy con-
trols, especially children [15,16]. Nevertheless, the overall
prevalence of C. concisus in faecal samples seems to be under-
reported because the time-consuming ﬁlter method is not
used in routine diagnostics in favour of a selective media for
cultivation of Campylobacter species. In this paper we describe
the incidence of C. concisus in unselected clinical diarrhoeic fae-
cal samples from the population in North Jutland, Denmark.
Materials and Methods
Study population
In the study period from January 2009 to December 2010
the Department of Clinical Microbiology, Aalborg Hospital,
Aarhus University Hospital, Denmark, provided microbiologi-
cal services for seven hospitals and 355 general practitioners
in the North Denmark region with a background population
of 580 515 inhabitants in a mixed urban and rural commu-
nity. A total of 29 242 human diarrhoeic stool samples were
cultured for pathogenic enteric bacteria by routine methods
as described previously [17].
Isolation of Campylobacter species
In Denmark, Campylobacter species have been isolated using
the selective media, the modiﬁed charcoal cefoperazone
deoxycholate agar (mCCDA; SSI Diagnostica, Hillerød,
Denmark) whereas the time-consuming ﬁlter method has
not been used routinely. To assess the incidence of non-
thermophilic Campylobacter species we randomly selected on
a daily basis 11 314 (39%) human diarrhoeic stool samples
which were cultured with the addition of the ﬁlter method
as described elsewhere [15]. Stool samples from 108 healthy
volunteers, mainly staff members and children with no his-
tory of gastrointestinal illnesses or antibiotic treatment, were
also cultivated using the ﬁlter method.
Identiﬁcation of Campylobacter species
Campylobacter jejuni/coli were routinely identiﬁed by their
macroscopic morphology on the mCCDA plates, by their
swarming growth on the 5% horse blood agar plate with
extra yeast extract and by a positive wet smear of highly
motile spiral bacteria. Differentiation between C. jejuni and
C. coli was not performed. Antimicrobial susceptibility testing
was performed using Neo-Sensitabs (Rosco Diagnostica A/
S, Taastrup, Denmark) with CLSI potencies according to the
manufacturer’s instructions. Campylobacter jejuni/coli were
tested for resistance against erythromycin (15 lg) and cipro-
ﬂoxacin (5 lg) on 5% horse blood agar plate (SSI Diagnosti-
ca). Non-thermophilic Campylobacter species were identiﬁed
as highly motile, gram-negative spiral, s-shaped or curved
rods with a negative L-alanyl aminopeptidase (L-ALA test;
O.B.I.S Campy, Oxoid, Cambridge, UK). Non-thermophilic
Campylobacter species were tested for hydrogen sulphide
production in triple sugar iron medium (SSI Diagnostica),
hydrolysis of indoxyl acetate (Diatabs; Rosco Diagnostica
A/S), resistance to nalidixic acid (30 lg) and sensitivity to
cephalothin (30 lg) for a presumptive diagnosis. Sensitivity
for azithromycin (15 lg), ciproﬂoxacin (5 lg), tetracycline
(30 lg) and amoxicillin (30 lg) was tested on a 5% horse
blood agar plate containing 1% yeast extract. Final identiﬁca-
tion of all non-thermophilic Campylobacter species was car-
ried out using a species-speciﬁc real-time PCR based on the
cpn60 gene, as described by Chaban et al. [18]. Reference
strains were used as positive controls (C. concisus ATCC
33237, Campylobacter upsaliensis ATCC 43954 and Campylo-
bacter curvus ATCC 35224).
Travel exposure and contact with animals
Data regarding recent travel exposure and contact with ani-
mals were reviewed by using a questionnaire survey. Travel
exposure was simply deﬁned as travel outside Denmark,
regardless of the purpose, within 2 weeks before the onset
of diarrhoea. Patients were requested by telephone to par-
ticipate in the survey by the clinical investigator. All patients
who participated in the investigation signed a written
informed consent form. For children the informed consent
was obtained from their parents. Scientiﬁc and ethics
approval for the study was obtained from The Ethics Com-
mittee for North Denmark Region, Denmark (N-20080056).
Results
Study population and overall prevalence of pathogenic
enteric bacteria
The 8302 patients had a median age of 45 years (interquar-
tile range (IQR), 20–67 years) and compised 4535 (55%)
women and 3767 (45%) men. In the 2-year study period
1532 patients (median 46 years; IQR 22–67 years) were
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identiﬁed with a pathogenic enteric bacterium in their diar-
rhoeic stool sample (Table 1). Two-hundred and ﬁfty-ﬁve
patients had more than one positive faecal sample giving a
total of 1872 isolates. Sixty-seven per cent of the patients
(5565 patients) were seen in general practice and the
remaining 33% (2737 patients) were hospitalized.
Prevalence of Campylobacter species
All strains of non-thermophilic Campylobacter species were
isolated using the ﬁlter method only, whereas the C. jejuni/coli
were isolated using the mCCDA-medium as well as the ﬁlter
method. There was no signiﬁcant difference in the recovery
rate between the two isolation procedures. The most preva-
lent Campylobacteraceae were C. jejuni/coli with 489 patients
(median 33 years; IQR 19–50 years). Nearly as frequent was
C. concisus with 400 patients (median 52 years; IQR 21–
68 years) corresponding to an average annual incidence of
35/100 000 inhabitants. There was a very low prevalence of
other non-thermophilic Campylobacter species and C. curvus
(n = 5) and C. upsaliensis (n = 2) were the only ones culti-
vated in this study. We also cultivated one isolate of the
close-related Arcobacter cryaerophilus (using the MALDI-TOF
(matrix-assisted laser desorption/ionization-time of ﬂight)
Biotyper for identiﬁcation, data not shown). One hundred
and forty (35%) patients infected with C. concisus were hospi-
talized and 260 patients were seen in general practice. Only
102 (21%) patients infected with C. jejuni/coli were hospital-
ized. For both Campylobacter groups there was a similar hos-
pitalization rate (data not shown) in all age groups, and half
of all elderly patients were hospitalized.
No Campylobacteraceae was cultured in stool samples
from healthy volunteers (median 14 years; range 0–69 years,
with equal sex ratio). Co-infections with Clostridium difﬁcile
were twice as frequent in C. concisus-infected patients (n = 22)
compared with patients with C. jejuni/coli (n = 11) and concur-
rent detection of Salmonella enterica was even higher with
more than triple frequency in C. concisus patients (n = 18)
compared with patients with C. jejuni/coli (n = 5). Two patients
had C. concisus as well as C. jejuni/coli in their faecal sample, and
three C. concisus patients had co-infections with Plesiomonas
shigelloides, Yersinia enterocolitica, or Shigella sonnei, respectively.
Incidence of Campylobacter concisus and Campylobacter
jejuni/coli
Both C. concisus and C. jejuni/coli were isolated from patients
of all ages; however, the age-speciﬁc incidences showed that
C. concisus as well as C. jejuni/coli were frequent among tod-
dlers. Campylobacter concisus was also frequent among very
small children (<1 year) and older patients whereas C. jejuni/
coli were frequent in young adults (Fig. 1).
Seasonal inﬂuence
We found a high prevalence of C. jejuni/coli from June to
October (Fig. 2). There was a more constant prevalence of
C. concisus during the study period. Furthermore, C. concisus
was isolated in a rather high number during the winter
months, especially in March, where C. jejuni/coli were isolated
in a low number.
Phenotype characteristics and antimicrobial resistance
Phenotype characteristics and antimicrobial resistance are
presented in Table 2. We observed a very low number of
C. concisus isolates resistant to macrolide, tetracycline and
amoxicillin. The isolates of C. jejuni/coli also showed very low
macrolide resistance. In contrast, there was a high resistance
toward ciproﬂoxacin in both C. jejuni/coli isolates (34%) and
C. concisus isolates (16%). Isolates of C. concisus were not
TABLE 1. Number of patients and isolates with pathogenic
enteric bacteria in 11 314 diarrhoeic stool samples from
8302 patients, North Jutland, Denmark
Microorganism Patients Isolates
Campylobacteraceae
Campylobacter jejuni/coli 489 541
Campylobacter concisus 400 441
Campylobacter curvus 5 5
Campylobacter upsaliensis 2 2
Arcobacter cryaerophilusa 1 1
Other bacteria
Clostridium difﬁcileb 379 546
Salmonella enterica serovar Typhimurium 75 93
Salmonella enterica 72 81
Salmonella enterica serovar Enteritidis 64 76
Shigella species 20 29
Yersinia enterocolitica 15 21
Escherichia coli, (EHEC) 6 6
Otherc 4 5
Total 1532 1847
aIdentiﬁed with use of the MALDI-TOF (matrix-assisted laser desorption/ioniza-
tion-time of ﬂight) biotyper.
bSamples were not cultured for Clostridium difﬁcile if they were from children
<2 years of age or patients with a travel exposure.
cPlesiomonas shigelloides, Yersinia enterocolitica and Aeromonas sobria.
FIG. 1. Age-related annual incidence of Campylobacter concisus
(white) and Campylobacter jejuni/coli (black) gastroenteritis in North
Jutland, Denmark.
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solely positive or negative in triple sugar iron medium or
indoxyl acetate hydrolysis. This makes it difﬁcult to obtain a
phenotypic distinction for this species.
Travel exposure and animal contact
Two hundred and seventy-one patients (68%) with C. concisus
and 335 patients (69%) with C. jejuni/coli gave consent to par-
ticipate in the questionnaire survey. The questionnaire was
returned by 216 C. concisus patients (80%) and 260 C. jejuni/
coli patients (78%). Travel exposure was signiﬁcantly higher
among patients with C. jejuni/coli, and they also had more fre-
quent contact with animals, especially dogs (Table 3).
Discussion
The present report is the ﬁrst to describe the clinical epide-
miology of C. concisus in diarrhoeic stool samples in an unse-
lected population-based community. We found a high
incidence of C. concisus, almost as high as the common
C. jejuni/coli, in samples from patients with gastroenteritis
from a mixed urban and rural community. This demonstration
of high incidence of C. concisus is based on a large sample size.
Nevertheless, the overall incidence in North Jutland might be
twice as high if we had examined all samples, because only
39% of all faecal specimens were included in the study.
Earlier reports have cultured C. concisus in paediatric diar-
rhoeic stool samples as well as in immunocompromised
patients [15,16]. In contrast to The Red Cross Children’s
Hospital in Cape Town, South Africa, which has isolated
Campylobacter species since 1977, we had a very low yield of
other non-thermophilic Campylobacter species, such as C. up-
saliensis [2]. This may be explained by the signiﬁcant tertiary
service they provide, whereas our results are from an unse-
lected population-based community. Campylobacter concisus
was frequent among infants (<1 year) and toddlers but was
also frequent among older patients whereas C. jejuni/coli were
most frequent in young adults. The difference in age distribu-
tion may explain the differences in hospitalization between
FIG. 2. Monthly percentages of positive samples with either Campylobacter concisus (white, n = 400) or Campylobacter jejuni/coli (black, n = 489)
in North Jutland, Denmark. The corresponding sample size is given in brackets.
TABLE 2. Phenotypic characteristics and antimicrobial
resistance of C. concisus and C. jejuni/coli
C. concisus
(N = 441)
C. curvus
(N = 5)
C. upsaliensis
(N = 2)
C. jejuni/coli
(N = 541)
Phenotypic characteristics
Negative
L-ALA testa
441 5 2 –
TSIb 335 4 0 –
Indoxyl acetate
hydrolysis
15 1 0 –
Antimicrobial resistancec –
Nalidixic
acid (IDd)
364 5 1 –
Cephalothin (ID) 0 0 0 –
Tetracyclin 2 0 0 –
Ampicillin 1 0 1 –
Macrolidee 4 0 0 5
Ciproﬂoxacin 69 0 0 184
aEnzyme L-alanyl aminopeptidase (L-ALA).
bHydrogen sulﬁde production in triple sugar iron medium.
cUsing Neo-Sensitabs (Rosco Diagostica A/S).
dOnly for presumptive diagnostics.
eCampylobacter jejuni/coli were tested with erythromycin and C. concisus with azi-
thromycin.
TABLE 3. Travel exposure and animal contact among 216
patients with C. concisus and 260 patients with C. jejuni/coli
gastroenteritis, North Jutland, Denmark
C. concisus
(n = 216)
C. jejuni/coli
(n = 260) p-valuea
Travel exposureb 24 (11%) 73 (28%) <0.001
Contact with animalsc 80 (37%) 134 (52%) <0.01
Dogs 44 (20%) 89 (34%) <0.01
Cats 35 (16%) 57 (22%) 0.18
Otherd 21 (10%) 31 (12%) 0.65
aFisher’s exact test was used for dichotomous variables.
bTravel destinations (UN geographical sub regions) among C. concisus patients:
Northern Europe = 2, Western Europe = 2, Eastern Europe = 2, Southern Eur-
ope = 5, Northern Africa = 5, Western Asia = 5, Eastern Asia = 1, Central
America = 1, and South America = 1; and among C. jejuni/coli patients: Northern
Europe = 2, Western Europe = 10, Eastern Europe = 4, Southern Europe = 15,
Northern Africa = 9, Eastern Africa = 2, Western Asia = 10, Southern Asia = 7,
Eastern Asia = 2, South-eastern Asia = 8, Western Africa = 1, Southern
Africa = 2, Unknown destination = 1.
cSeventeen C. concisus and 36 C. jejuni/coli patients had contact with two animals
or more.
dIncludes: hamsters, pigs, sheep’s, chickens, birds, pigeons, goats, horses and rab-
bits.
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C. concisus and C. jejuni/coli patients but there is an urgent
need of clinical data.
Around 10% of the patients with C. consisus had another
pathogenic enteric bacterium in their stool sample, whereas
this was <5% for C. jejuni/coli patients. Co-infections were
predominant in elderly patients and dominated by Clostridium
difﬁcile and S. enterica. The C. jejuni/coli patients were mainly
small children and young adults, which might explain the
lower number of co-infections with Clostridium difﬁcile. How-
ever, the large difference in age distribution between C. conci-
sus and C. jejuni/coli cannot explain the more than threefold
difference in co-infection with S. enterica.
We did not culture any C. concisus in stool samples in the
small cohort of healthy individuals. This conﬂicts with earlier
reports in which C. concisus occasionally could be cultured in
healthy controls, especially children, challenging the role of
C. concisus in gastrointestinal disease [15,16]. The small sam-
ple size gives our study limited power to rule out a presence
of C. concisus in healthy individuals. However, a large healthy
cohort of different age groups, with both oral and faecal
samples, is required for a deﬁnitive description of the true
prevalence of C. concisus in asymptomatic individuals.
We observed a seasonal variation in C. jejuni/coli with a
peak incidence in late summer months and autumn as
described earlier [19,20]. In contrast there was an almost
constant prevalence of C. concisus. The reason for this is
unclear but it may be explained by differences in reservoir. If
the primary reservoir for C. concisus is the human oral cavity
it would be interesting to know if the diarrhoeal disease is
caused by the patients’ oral commensal strains of C. concisus
or by an exposure for a person-to-person transmission of a
virulent strain of C. concisus.
Recently, C. concisus was reported in fresh chicken meat
and minced beef [3]. To determine C. concisus as a zoonotic
infection, stool samples from poultry, pigs and cattle have to
be investigated for C. concisus. Campylobacter concisus has also
been reported in faecal samples from domestic dogs, so pets
and close contact with animals might be a source of infection,
as occasionally reported for C. jejuni/coli and C. upsaliensis [21].
However, our C. concisus patients had a lower degree of close
contacts with animals, especially contacts with dogs, compared
with C. jejuni/coli patients. Moreover, we would expect more
isolates of C. upsaliensis in the present study if dogs were the
patients’ true source of infection, so the main conclusion is
that transmission from pets is of minor importance.
In our study, a signiﬁcantly higher proportion of patients
with C. jejuni/coli had travel exposure and a high level of cip-
roﬂoxacin resistance was found. Since 1998, the Red Cross
Children’s Hospital (Cape Town, South Africa) reported
increasing ciproﬂoxacin resistance levels from 6.9% to 18%
in C. concisus isolates [22]. We detected a very similar cipro-
ﬂoxacin resistance level of 16% for our C. concisus isolates. In
contrast to the rising resistance level toward macrolide of
21.7% by the Red Cross Children’s Hospital we found a very
low resistance level in C. jejuni/coli and C. concisus. So far,
there are no data on whether patients with C. concisus may
beneﬁt from antimicrobial treatment. Clinical trials are
needed to investigate a potential beneﬁcial effect of antibiot-
ics. However, before these studies are performed, investiga-
tions strengthening the evidence of the pathogenicity of
C. concisus are necessary.
In conclusion, we found a high incidence of C. concisus,
almost equal to C. jejuni/coli, in patients with gastroenteritis
in an unselected population-based community. Our study
was based on a large sample size, and although the distribu-
tion of the different Campylobacter species will be the same,
the overall incidence might be twice as high. In contrast to
earlier studies, we had a very low prevalence of other non-
thermophilic Campylobacter species, such as C. upsaliensis.
Additional laboratory and clinical studies are required to elu-
cidate the pathogenic role of C. concisus. There is an urgent
need of clinical follow-up of C. concisus patients and knowl-
edge about the clinical outcome in different age groups, for
example, the long-term risk of inﬂammatory bowel diseases
in the years after C. concisus has to be investigated.
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